Fig. 5: Survival curve for naive and semi-immune groups. | Nature Communications

Fig. 5: Survival curve for naive and semi-immune groups.

From: Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine

Fig. 5

Protective efficacy Kaplan–Meier curves are shown for naive (a) and semi-immune (b) groups. One volunteer of the semi-immune Ctrl group (red line) did not develop parasitemia. Exp: Experimental (blue lines), Ctrl: Control. Prepatent periods of the Exp naive (15.8) and semi-immune (17.6) groups presented significant differences (p = 0.0034). Source data are provided as a Source data file.

Back to article page